Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
108.25
(
0.72%
)
Bitcoin
76,792.00
(
-0.80%
)
News Focus
News Focus
Post# of 2446
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: aslan2772 post# 381

Tuesday, 09/12/2006 4:41:22 PM

Tuesday, September 12, 2006 4:41:22 PM

Post# of 2446
>I disagree. For one, the STRIDE data are very good, IMHO…<

Our views of the I-vation data are probably closer than you think. All I meant was that the data are not the blowout result that might have caused InnoRx insiders and affiliates to hang on to their shares for a really big pop.

>…are you suggesting InnoRx insiders had access to data back in May/June?<

They may have—the trial was open-label.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SRDX News
More SRDX News